Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
22.29
-0.46 (-2.02%)
At close: Oct 17, 2025, 4:00 PM EDT
22.25
-0.04 (-0.18%)
After-hours: Oct 17, 2025, 7:00 PM EDT
Phreesia Revenue
Phreesia had revenue of $117.26M in the quarter ending July 31, 2025, with 14.83% growth. This brings the company's revenue in the last twelve months to $449.67M, up 15.31% year-over-year. In the fiscal year ending January 31, 2025, Phreesia had annual revenue of $419.81M with 17.83% growth.
Revenue (ttm)
$449.67M
Revenue Growth
+15.31%
P/S Ratio
2.91
Revenue / Employee
$215,981
Employees
2,082
Market Cap
1.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 419.81M | 63.51M | 17.83% |
Jan 31, 2024 | 356.30M | 75.39M | 26.84% |
Jan 31, 2023 | 280.91M | 67.68M | 31.74% |
Jan 31, 2022 | 213.23M | 64.56M | 43.42% |
Jan 31, 2021 | 148.68M | 23.89M | 19.15% |
Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PHR News
- 9 days ago - Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling - Business Wire
- 17 days ago - Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies - Business Wire
- 4 weeks ago - Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare - Business Wire
- 5 weeks ago - Holding Phreesia Despite Initial Post-Earnings Disappointment - Seeking Alpha
- 6 weeks ago - Phreesia Analysts Raise Their Forecasts After Q2 Results - Benzinga
- 6 weeks ago - Analysts Weigh Integration Risks As Phreesia Expands With New Deal - Benzinga
- 6 weeks ago - Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Phreesia Announces Second Quarter Fiscal 2026 Results - Business Wire